THE PROBLEM:
Publicly traded late-stage therapeutics company negotiates with, and enters into, collaboration / license arrangement with a big pharma partner.
THE SOLUTION:
Forecasting, market research, modeling and transaction support combined with resultant collaboration agreement accounting analyses.
“You were a great support for us, responsive and knowledgeable. Thank you!” CFO
“You are my top go to valuation firm for my life science companies since you actually understand the industry.” – Audit Partner
